|
Name |
Geumsanol G
|
Molecular Formula | C19H27ClO6 | |
IUPAC Name* |
(7R,8R,8aR)-5-chloro-3-[(E,3R,4R,5S)-3,4-dihydroxy-3,5-dimethylhept-1-enyl]-7,8-dihydroxy-7-methyl-8,8a-dihydro-1H-isochromen-6-one
|
|
SMILES |
CC[C@H](C)[C@H]([C@@](C)(/C=C/C1=CC2=C(C(=O)[C@]([C@@H]([C@H]2CO1)O)(C)O)Cl)O)O
|
|
InChI |
InChI=1S/C19H27ClO6/c1-5-10(2)15(21)18(3,24)7-6-11-8-12-13(9-26-11)16(22)19(4,25)17(23)14(12)20/h6-8,10,13,15-16,21-22,24-25H,5,9H2,1-4H3/b7-6+/t10-,13-,15+,16+,18+,19+/m0/s1
|
|
InChIKey |
CPMFRQHRPWPNMP-BGENANHXSA-N
|
|
Synonyms |
Geumsanol G; J3.569.365C
|
|
CAS | NA | |
PubChem CID | 132578870 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 386.9 | ALogp: | 1.0 |
HBD: | 4 | HBA: | 6 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 107.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 26 | QED Weighted: | 0.575 |
Caco-2 Permeability: | -4.78 | MDCK Permeability: | 0.00001480 |
Pgp-inhibitor: | 0.01 | Pgp-substrate: | 0.977 |
Human Intestinal Absorption (HIA): | 0.13 | 20% Bioavailability (F20%): | 0.117 |
30% Bioavailability (F30%): | 0.013 |
Blood-Brain-Barrier Penetration (BBB): | 0.654 | Plasma Protein Binding (PPB): | 87.84% |
Volume Distribution (VD): | 2.17 | Fu: | 13.51% |
CYP1A2-inhibitor: | 0.033 | CYP1A2-substrate: | 0.183 |
CYP2C19-inhibitor: | 0.023 | CYP2C19-substrate: | 0.814 |
CYP2C9-inhibitor: | 0.009 | CYP2C9-substrate: | 0.09 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.057 |
CYP3A4-inhibitor: | 0.103 | CYP3A4-substrate: | 0.232 |
Clearance (CL): | 2.268 | Half-life (T1/2): | 0.713 |
hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.147 |
Drug-inuced Liver Injury (DILI): | 0.969 | AMES Toxicity: | 0.34 |
Rat Oral Acute Toxicity: | 0.85 | Maximum Recommended Daily Dose: | 0.981 |
Skin Sensitization: | 0.931 | Carcinogencity: | 0.41 |
Eye Corrosion: | 0.09 | Eye Irritation: | 0.315 |
Respiratory Toxicity: | 0.974 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001875 | 0.630 | D02ZGI | 0.210 | ||||
ENC005432 | 0.614 | D0L7AS | 0.193 | ||||
ENC005429 | 0.586 | D0T2PL | 0.190 | ||||
ENC005430 | 0.586 | D05BTM | 0.190 | ||||
ENC005431 | 0.570 | D02XSA | 0.186 | ||||
ENC001871 | 0.474 | D0C8HR | 0.185 | ||||
ENC001877 | 0.474 | D02GAC | 0.185 | ||||
ENC005595 | 0.444 | D0R6RC | 0.185 | ||||
ENC004213 | 0.442 | D02VPX | 0.184 | ||||
ENC001884 | 0.429 | D04VIS | 0.183 |